1. KSA National Plan
RESEARCH AGENDA
Abdulaziz AlSwailem, PhD.
Vice President for Scientific Research Support,
KACST
Riyadh- Sept 11, 2012 – Int. conf. on NCD
1

2. Agenda
1. What is KACST
2. Why do we exist (KACST)
3. Where KACST stands from Medical Research?
A. A proved of Kingdom’s NSTIP.
B. Strategic Priorities: Medical and Health Research.
C. Funding.
D. Innovation Chain.
E. Progress.
2

3. 1. What is KACST:
• An independent scientific organization.
• Function involves science and technology policy making, data
collection, funding of external research.
• KACST has currently over 2500 employees.
3

4. 2. Why Do We Exist?
Research
National planning performance
- Long term goals
- Research institution
- Five years planning
- Research centers
Production of science Research support
and technology - Financial support
- Incubator -Information, Patent, Media
- Manufacturing …
4

5. To be a world-class science and technology
organization that fosters innovation and
promotes knowledge-based society in the
Kingdom.
5

6. 3. Where KACST stands from Medical Research:
A. A proved of Kingdom’s NSTIP
2025 –
Transform to
2020 - a knowledge
Become a based
leading economy Join the
country in and society advanced
2015 - STI in Asia knowledge-based
Become a
leading
economies with
country in STI highly
in the region competitive STI
2010 – ecosystem by
Establish
infrastructure 2025
for STI
KSA National Science
and Technology Policy
6

7. A. A proved of Kingdom’s NSTIP: Continue…
Fig 1: Science and Technology Programs
7

8. B. Strategic Priorities for Advanced Medical and Health Research
(2008- 2012) :
Selected Priority Research Areas:
 Non-Communicable Diseases
1. Cardiovascular Diseases
2. Diabetes
3. Cancer
4. Allergy & Asthma
5. Neurodegenerative Diseases
 Communicable Diseases
 Genetics
 Cell Therapy
 Disability
 Environmental Health
8

9. C. Funding (2001-2011):
KSU MS-MinDEF KFSH-RC KAU QU ALFAISAL KSU KAU KFSH-RC Sul-HC KFNGH TU UQU KSU-HS SaadSH KKU UD KFU
Fig 2: NSTIP Funded Research Institutions Fig 3: KACST Direct Funded Research Institutions
9

10. C. Funding: Continue…
Fig 4 : % NSTIP Funding for Technology Areas Fig 5: %Direct Funding for Technology Areas
10

11. D. Innovation chain:
TRANSITIONAL RESEARCH REGULATIONS
 SBIR  Bioethics
 Saudi Business Innovation Research  Code Of ethics
 BADER  Stem Cells, Cloning, Genetic data
 The Centennial fund  Bio-safety
 Small and Medium business  Cartagena protocol
 Entrepreneurs  Clinical Trails
 Saudi Industrial Development Fund  Bio-Diversity

12. E. Progress:
Fig 6 : Medical Publication of Research Institutions
12

13. E. Progress: Continue…
Fig 7 : Average annual citation impact of countries in the
Arabian, Persian & Turkish Middle East
13

14. Your turn…!
Abdulaziz Alswailem, PhD.
alswailem@kacst.edu.sa